Live tape
Top 8, mentions 7d13,317TSLA3,156 mentions▲ +0.05SPCX2,590 mentions▲ +0.08GOOGL1,761 mentions▲ +0.03META1,707 mentions▲ +0.05QQQ1,049 mentions▲ +0.05NVDA1,030 mentions▲ +0.07NFLX1,013 mentions▲ +0.03CRWV1,011 mentions▲ +0.04

Equity · Healthcare

GNPX

NASDAQ

Genprex (GNPX)

$7 −12.50% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for GNPX to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $5.7M
P/E (TTM) 0.0
Avg volume 25.1K

as of Jul 17, 2026

Genprex (GNPX) insider trades

SEC Form 4

GNPX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 14 April 2026.

Date Insider Type Shares Value
14 Apr 2026 LONGNECKER BRENT M Director Sell 18 $0K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
27 Feb 2026 Berger Mark Stanley Chief Medical Officer Tax withheld 7,168 $14K
27 Feb 2026 Confer Ryan M. President, CEO and CFO Tax withheld 9,330 $19K
22 Dec 2025 Moreno Toscano Jose Antonio Director Award 9,000
22 Dec 2025 Berger Mark Stanley Chief Medical Officer Award 28,500
22 Dec 2025 Confer Ryan M. President, CEO and CFO Award 45,000
22 Dec 2025 LONGNECKER BRENT M Director Award 9,000
22 Dec 2025 Wilson William R Jr. Director Award 9,000

Genprex (GNPX) reported financials

SEC EDGAR XBRL SEC EDGAR

Genprex reported net income of −$16.2M for the fiscal year ended 31 Dec 2025.

Figure Reported Period
Net income −$16.2M 31 Dec 2025 fiscal year
Earnings per share basic −$17.40 31 Dec 2025 fiscal year
Total assets $17.1M 30 Jun 2026 at period end
Total equity $14.8M 30 Jun 2026 at period end

Genprex (GNPX) earnings

SEC EDGAR

Genprex last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$9.40; no next date is announced in SEC filings yet.

Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$9.40 —
31 Mar 2026 Q1 2026 −$0.64 —
31 Dec 2025 FY 2025 −$17.40 —
30 Sep 2025 Q3 2025 −$5.00 —
30 Jun 2025 Q2 2025 −$185.30 —
31 Mar 2025 Q1 2025 −$12.98 —
31 Dec 2024 FY 2024 −$266.89 —
30 Sep 2024 Q3 2024 −$61.65 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

Genprex (GNPX) fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 9,437 shares of Genprex failed to deliver (about $27K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 9,437 $27K 1.151%
28 Sep 2026 158 $520 0.019%
25 Sep 2026 4,282 $15K 0.522%
24 Sep 2026 20,660 $77K 2.520%
18 Sep 2026 3,826 $13K 0.467%
17 Sep 2026 2,219 $8K 0.271%
16 Sep 2026 1,389 $5K 0.169%
15 Sep 2026 80 $276 0.010%
10 Sep 2026 2,697 $9K 0.329%
09 Sep 2026 2,756 $10K 0.336%
08 Sep 2026 7,687 $27K 0.938%

Congressional trades in Genprex (GNPX)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Genprex is a purchase by Tim Moore (house, NC), dated 18 Dec 2025.

Date Member Type Amount
18 Dec 2025 filed 07 Jan 2026 Tim Moore house · Republican–NC Purchase $1K–$15K
07 Nov 2025 filed 02 Dec 2025 Tim Moore house · Republican–NC Purchase $1K–$15K

Genprex (GNPX): frequently asked questions

From live data

Have Genprex insiders bought or sold shares recently?

No Genprex insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 14 Apr 2026 (SEC Form 4).

Has Genprex had fails-to-deliver recently?

Yes. The most recent SEC fails-to-deliver record for Genprex is dated 30 Sep 2026, when 9,437 shares failed to deliver.

When did Genprex last report earnings?

Genprex last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$9.40; no next date is announced in SEC filings yet.

What exchange is Genprex listed on?

Genprex trades on NASDAQ under the ticker GNPX.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SECSEC fails-to-deliver (CNS) data
  5. House disclosuresU.S. House of Representatives financial disclosures
  6. SEC EDGARValuation computed from SEC EDGAR filings